IMRT appears safe, effective at 5-year follow-up in early-stage breast cancer

Intensity-modulated radiotherapy appeared associated with good local control and few side effects in women with early-stage breast cancer at 5-year follow-up, according to first results of the phase 3 IMPORT LOW trial presented at the 10th European Breast Cancer Conference.